About 1 result found for searched term "2169919-21-3" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13387 | Revumenib (SNDX-5613) | Epigenetic Reader Domain |
| SNDX5613 | ||
| Revumenib (SNDX-5613) is a first-in-class, effective and selective Menin-MLL binding inhibitor with Ki of 0.15 nM. Revumenib (SNDX-5613) can be used to study MLL gene rearrangement in acute leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
